<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0017169"><a href="http://purl.obolibrary.org/obo/MONDO_0017169">MONDO:0017169</a></h3>
<p><strong>Label:</strong> multiple endocrine neoplasia</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0019003">MONDO:0019003</a> (multiple endocrine neoplasia type 2),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://purl.obolibrary.org/obo/OMIM_162300">OMIM:162300</a>, <a href="http://purl.obolibrary.org/obo/OMIM_155240">OMIM:155240</a>, <a href="http://purl.obolibrary.org/obo/OMIM_171400">OMIM:171400</a>, <a href="http://www.orpha.net/ORDO/Orphanet_653">Orphanet:653</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0002865">HP:0002865</a> (Medullary thyroid carcinoma) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003005">HP:0003005</a> (Ganglioneuroma) and <a href="http://purl.obolibrary.org/obo/HP_0100634">HP:0100634</a> (Neuroendocrine neoplasm) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003005">HP:0003005</a> (Ganglioneuroma) and <a href="http://purl.obolibrary.org/obo/HP_0040069">HP:0040069</a> (Abnormality of lower limb bone) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003005">HP:0003005</a> (Ganglioneuroma) and <a href="http://purl.obolibrary.org/obo/HP_0040068">HP:0040068</a> (Abnormality of limb bone) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002865">HP:0002865</a> (Medullary thyroid carcinoma) and <a href="http://purl.obolibrary.org/obo/HP_0003005">HP:0003005</a> (Ganglioneuroma) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002813">HP:0002813</a> (Abnormality of limb bone morphology) and <a href="http://purl.obolibrary.org/obo/HP_0003005">HP:0003005</a> (Ganglioneuroma) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002666">HP:0002666</a> (Pheochromocytoma) and <a href="http://purl.obolibrary.org/obo/HP_0003005">HP:0003005</a> (Ganglioneuroma) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001761">HP:0001761</a> (Pes cavus) and <a href="http://purl.obolibrary.org/obo/HP_0003005">HP:0003005</a> (Ganglioneuroma) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000828">HP:0000828</a> (Abnormality of the parathyroid gland) and <a href="http://purl.obolibrary.org/obo/HP_0003005">HP:0003005</a> (Ganglioneuroma) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003005">HP:0003005</a> (Ganglioneuroma) and <a href="http://purl.obolibrary.org/obo/HP_0100634">HP:0100634</a> (Neuroendocrine neoplasm) and <a href="http://purl.obolibrary.org/obo/HP_0410008">HP:0410008</a> (Abnormality of the peripheral nervous system) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003005">HP:0003005</a> (Ganglioneuroma) and <a href="http://purl.obolibrary.org/obo/HP_0100568">HP:0100568</a> (Neoplasm of the endocrine system) and <a href="http://purl.obolibrary.org/obo/HP_0410008">HP:0410008</a> (Abnormality of the peripheral nervous system) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003005">HP:0003005</a> (Ganglioneuroma) and <a href="http://purl.obolibrary.org/obo/HP_0100031">HP:0100031</a> (Neoplasm of the thyroid gland) and <a href="http://purl.obolibrary.org/obo/HP_0410008">HP:0410008</a> (Abnormality of the peripheral nervous system) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003005">HP:0003005</a> (Ganglioneuroma) and <a href="http://purl.obolibrary.org/obo/HP_0100031">HP:0100031</a> (Neoplasm of the thyroid gland) and <a href="http://purl.obolibrary.org/obo/HP_0100634">HP:0100634</a> (Neuroendocrine neoplasm) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003005">HP:0003005</a> (Ganglioneuroma) and <a href="http://purl.obolibrary.org/obo/HP_0040069">HP:0040069</a> (Abnormality of lower limb bone) and <a href="http://purl.obolibrary.org/obo/HP_0100634">HP:0100634</a> (Neuroendocrine neoplasm) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003005">HP:0003005</a> (Ganglioneuroma) and <a href="http://purl.obolibrary.org/obo/HP_0040069">HP:0040069</a> (Abnormality of lower limb bone) and <a href="http://purl.obolibrary.org/obo/HP_0100568">HP:0100568</a> (Neoplasm of the endocrine system) 75.00%</li>
</ul>
</body>
</html>
